BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome positive leukemias

Dan Jones, Rajyalakshmi Luthra, Jorge Cortes, Deborah Thomas, Susan O'Brien, Carlos Bueso-Ramos, Seema Hai, Farhad Ravandi, Marcos De Lima, Hagop Kantarjian, Jeffrey L. Jorgensen

Research output: Contribution to journalArticle

Abstract

It remains unresolved how different BCR-ABL transcripts differentially drive lymphoid and myeloid proliferation in Philadelphia chromosome-positive (Ph +) leukemias. We compared BCR-ABL transcript type and level with kinase domain (KD) mutation status, genotype, and phenotype in 1855 Ph + leukemias. Compared with e1a2/p190 BCR-ABL cases, de novo e13-e14a2/p210 Ph + lymphoid leukemia more frequently showed CML-type back-ground, had higher blast-normalized BCR-ABL transcript levels, and more frequent persistent BCR-ABL transcript in the absence of detectable lymphoblasts. Secondary lymphoid blast transformation of CML was exclusively due to e13/e14a2/ p210 BCR-ABL but was associated, at a much higher level than p210 myeloid transformation, with acquisition of new KD mutations and/or Ph genomic amplification. In contrast, myeloid blast transformation was more frequently accompanied by new acquisition of acute myeloid leukemia-type chromosomal aberrations, particularly involving the EVI1 and RUNX1 loci. Therefore, higher kinase activity by mutation, transcriptional up-regulation or gene amplification appears required for lymphoid transformation by p210 BCR-ABL.

Original languageEnglish (US)
Pages (from-to)5190-5192
Number of pages3
JournalBlood
Volume112
Issue number13
DOIs
StatePublished - Dec 15 2008
Externally publishedYes

Fingerprint

Philadelphia Chromosome
Chromosomes
Emitter coupled logic circuits
Leukemia
Phosphotransferases
Fusion reactions
Phenotype
Lymphocyte Activation
Mutation
Aberrations
Lymphoid Leukemia
Amplification
Gene Amplification
Acute Myeloid Leukemia
Chromosome Aberrations
Up-Regulation
Genotype

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome positive leukemias. / Jones, Dan; Luthra, Rajyalakshmi; Cortes, Jorge; Thomas, Deborah; O'Brien, Susan; Bueso-Ramos, Carlos; Hai, Seema; Ravandi, Farhad; De Lima, Marcos; Kantarjian, Hagop; Jorgensen, Jeffrey L.

In: Blood, Vol. 112, No. 13, 15.12.2008, p. 5190-5192.

Research output: Contribution to journalArticle

Jones, Dan ; Luthra, Rajyalakshmi ; Cortes, Jorge ; Thomas, Deborah ; O'Brien, Susan ; Bueso-Ramos, Carlos ; Hai, Seema ; Ravandi, Farhad ; De Lima, Marcos ; Kantarjian, Hagop ; Jorgensen, Jeffrey L. / BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome positive leukemias. In: Blood. 2008 ; Vol. 112, No. 13. pp. 5190-5192.
@article{319221257b8a49e39808d8fa072cd00a,
title = "BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome positive leukemias",
abstract = "It remains unresolved how different BCR-ABL transcripts differentially drive lymphoid and myeloid proliferation in Philadelphia chromosome-positive (Ph +) leukemias. We compared BCR-ABL transcript type and level with kinase domain (KD) mutation status, genotype, and phenotype in 1855 Ph + leukemias. Compared with e1a2/p190 BCR-ABL cases, de novo e13-e14a2/p210 Ph + lymphoid leukemia more frequently showed CML-type back-ground, had higher blast-normalized BCR-ABL transcript levels, and more frequent persistent BCR-ABL transcript in the absence of detectable lymphoblasts. Secondary lymphoid blast transformation of CML was exclusively due to e13/e14a2/ p210 BCR-ABL but was associated, at a much higher level than p210 myeloid transformation, with acquisition of new KD mutations and/or Ph genomic amplification. In contrast, myeloid blast transformation was more frequently accompanied by new acquisition of acute myeloid leukemia-type chromosomal aberrations, particularly involving the EVI1 and RUNX1 loci. Therefore, higher kinase activity by mutation, transcriptional up-regulation or gene amplification appears required for lymphoid transformation by p210 BCR-ABL.",
author = "Dan Jones and Rajyalakshmi Luthra and Jorge Cortes and Deborah Thomas and Susan O'Brien and Carlos Bueso-Ramos and Seema Hai and Farhad Ravandi and {De Lima}, Marcos and Hagop Kantarjian and Jorgensen, {Jeffrey L.}",
year = "2008",
month = "12",
day = "15",
doi = "10.1182/blood-2008-04-148791",
language = "English (US)",
volume = "112",
pages = "5190--5192",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "13",

}

TY - JOUR

T1 - BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome positive leukemias

AU - Jones, Dan

AU - Luthra, Rajyalakshmi

AU - Cortes, Jorge

AU - Thomas, Deborah

AU - O'Brien, Susan

AU - Bueso-Ramos, Carlos

AU - Hai, Seema

AU - Ravandi, Farhad

AU - De Lima, Marcos

AU - Kantarjian, Hagop

AU - Jorgensen, Jeffrey L.

PY - 2008/12/15

Y1 - 2008/12/15

N2 - It remains unresolved how different BCR-ABL transcripts differentially drive lymphoid and myeloid proliferation in Philadelphia chromosome-positive (Ph +) leukemias. We compared BCR-ABL transcript type and level with kinase domain (KD) mutation status, genotype, and phenotype in 1855 Ph + leukemias. Compared with e1a2/p190 BCR-ABL cases, de novo e13-e14a2/p210 Ph + lymphoid leukemia more frequently showed CML-type back-ground, had higher blast-normalized BCR-ABL transcript levels, and more frequent persistent BCR-ABL transcript in the absence of detectable lymphoblasts. Secondary lymphoid blast transformation of CML was exclusively due to e13/e14a2/ p210 BCR-ABL but was associated, at a much higher level than p210 myeloid transformation, with acquisition of new KD mutations and/or Ph genomic amplification. In contrast, myeloid blast transformation was more frequently accompanied by new acquisition of acute myeloid leukemia-type chromosomal aberrations, particularly involving the EVI1 and RUNX1 loci. Therefore, higher kinase activity by mutation, transcriptional up-regulation or gene amplification appears required for lymphoid transformation by p210 BCR-ABL.

AB - It remains unresolved how different BCR-ABL transcripts differentially drive lymphoid and myeloid proliferation in Philadelphia chromosome-positive (Ph +) leukemias. We compared BCR-ABL transcript type and level with kinase domain (KD) mutation status, genotype, and phenotype in 1855 Ph + leukemias. Compared with e1a2/p190 BCR-ABL cases, de novo e13-e14a2/p210 Ph + lymphoid leukemia more frequently showed CML-type back-ground, had higher blast-normalized BCR-ABL transcript levels, and more frequent persistent BCR-ABL transcript in the absence of detectable lymphoblasts. Secondary lymphoid blast transformation of CML was exclusively due to e13/e14a2/ p210 BCR-ABL but was associated, at a much higher level than p210 myeloid transformation, with acquisition of new KD mutations and/or Ph genomic amplification. In contrast, myeloid blast transformation was more frequently accompanied by new acquisition of acute myeloid leukemia-type chromosomal aberrations, particularly involving the EVI1 and RUNX1 loci. Therefore, higher kinase activity by mutation, transcriptional up-regulation or gene amplification appears required for lymphoid transformation by p210 BCR-ABL.

UR - http://www.scopus.com/inward/record.url?scp=58149382596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149382596&partnerID=8YFLogxK

U2 - 10.1182/blood-2008-04-148791

DO - 10.1182/blood-2008-04-148791

M3 - Article

C2 - 18809762

AN - SCOPUS:58149382596

VL - 112

SP - 5190

EP - 5192

JO - Blood

JF - Blood

SN - 0006-4971

IS - 13

ER -